A paper arising from the ATP project that reviews case studies relating to product development and delivery by selected product development partnerships (PDP) is available as an open access publication:
Title: Product Development Partnerships: Case studies of a new mechanism for health technology innovation.
Journal: Health Research Policy and Systems 2011, 9:33
Author: Richard Mahoney. International Vaccine Institute (IVI)
There is a continuing need for new health technologies to address the disease burdens of developing countries. In the last decade Product Development Partnerships (PDP) have emerged that are making important contributions to the development of these technologies. PDPs are a form of public private partnerships that focus on health technology development. PDPs reflect the current phase in the history of health technology development: the Era of Partnerships, in which the public and private sectors have found productive ways to collaborate. Successful innovation depends on addressing six determinants of innovation. We examine four case studies of PDPs and show how they have addressed the six determinants to achieve success.
Download the paper here ….
The objectives of Socially Responsible Licensing (SRL) are mainly to ensure that licensing of intellectual assets is negotiated and transacted in a manner conducive to providing access to essential medicines and other life enhancing innovations. The goals of SRL are to make available to society globally, but in particular to developing countries, such technologies at affordable prices and to make proprietary research tools widely available for the advancement of knowledge. This can be achieved by adopting licensing practices which add a dimension of social responsibility to the pursuit of economic objectives, without necessarily compromising the latter. This approach does not affect business transactions in developed countries where significant profits can still be achieved but ensures access for the least developed countries, which are often disregarded in commercialization strategies due to perceived low profitability. This paper addresses recent developments in South Africa, specifically the newly enacted legislation on IP emanating from publicly funded research, and some practical examples of how SRL strategies can be implemented.
Socially Responsible Licensing Of Health Technologies- Policy And Practice In South Africa
Rabogajane Busang, Karine Boisjoly-Letourneau, Bernard Fourie, Michelle Mulder and Harry Thangaraj
Journal of the Licensing Executives Society International (les Nouvelles). June, 2011 – Volume XLVI No. 2
Recent Comments